Sialyllactose (SL) is an abundant oligosaccharide in human milk with health benefits that include intestinal maturation, gut microbiota modulation, and cognitive development. Recent technological advances support large scale production of different forms of sialyllactose, which will enable their use as a food ingredient. The objective of the study was to investigate the dose-dependent effects of novel enzymatically-synthesized 3′-sialyllactose (3′SL) sodium salt supplemented to swine milk replacer on growth, hematological parameters and tissue histology in a pre-clinical neonatal pig model. Forty-five two-day-old male and female pigs were provided one of four experimental diets for 21 days. Diets were formulated to contain 0 (CON), 140 (LOW), 200 (MOD) or 500 (HIGH) mg/L of 3′SL sodium salt. Samples were collected on days 8 and 22 of the study for hematological and histological analyses. The addition of 3′SL sodium salt to formula at all doses was well-tolerated by neonatal piglets and supported growth and development comparable to those observed in the CON group. In addition, serum chemistries as well as hematology and organ microscopic structure were unaffected by 3′SL (p > 0.05). These data provide supportive evidence for the safety of supplementation of this enzymatically-synthesized 3′SL sodium salt to human infant formula.
Introduction
Oligosaccharides represent the third most abundant component in human milk after lactose and fat (Bode and Jantscher-Krenn, 2012) . They are non-digestible extensions of lactose and are synthesized using a diverse number of glycosyltransferases that establish glycoside linkages with molecules such as N-acetyl-glucosamine, galactose, sialic acid or fucose (Chen, 2018) . Sialyltransferases are responsible for the binding of sialic acid to a lactose molecule to form the sialylated human milk oligosaccharides (HMO). Recently, a total of 30 sialylated HMO have been identified (Yan et al., 2018) , and among those, the predominant forms are 3′-sialyllactose (3′SL) and 6′-sialyllactose (6′SL). Milk concentration of 3′SL remains relatively stable throughout lactation and averages 222 mg/L (range of 26-477 mg/L), while 6′SL gradually declines from colostrum (529 mg/L) to mature milk (135 mg/L) (WHO, 2009; Sprenger et al., 2017) .
Many biological functions have been attributed to sialylated oligosaccharides in both in vitro and in vivo studies. Due to their similar structure to membrane-bound sialic acid binding sites for pathogens, sialyllactose (SL) had been found to inhibit the activity of cholera toxin to rabbit intestine loop model (Idota et al., 1995) , influenza binding in a type-and subtype-specific orchestrated fashion (Matrosovich et al., 1993) and rotavirus infectivity both in vitro and in vivo (Matrosovich et al., 1993) . Others have shown that dietary SL influences the microbiota composition in piglets (Jacobi et al., 2016) and in mice (Fuhrer et al., 2010) , and in human infants when a mixture of bovine milkderived oligosaccharides containing 3′SL and 6′SL was fed (Meli et al., 2014) . More importantly, SL has a direct impact on brain development and cognition when given as a single SL (Jacobi et al., 2016) or as a mixture of SL (Mudd et al., 2017) .
Human and bovine milk differ in their composition with respect to the amount and type of oligosaccharides. The sialylated oligosaccharides comprise 10-30% of total HMO, and concentration ranges from 3.72 mmol/L in colostrum to 0.73 mmol/L in mature milk. Sialylated oligosaccharides are the predominant oligosaccharides in bovine milk comprising 70% of total bovine milk oligosaccharides, but their overall concentration is only 9% of that found human milk (Nwosu et al., 2012; Martin-Sosa et al., 2003) . Most infant formulas are based on bovine milk as their starting material, therefore the concentrations of total and sialylated oligosaccharides are also low in infant formula (Martin-Sosa et al., 2003) .
The promising preclinical findings have fostered an interest in supplementing SL to formula (ten Bruggencate et al., 2014) . One option is to isolate SL from bovine milk whey permeate, however, a major challenge is the low concentration of SL and the potential for contamination with mono-and disaccharides (de Moura Bell et al., 2018) . To date, pure SL had not been available in sufficient amounts for clinical studies and ultimate addition to infant formula. To overcome this limitation, an option is a chemical synthesis, however, oligosaccharide synthesis is not as straightforward as DNA synthesis and still presents a challenge to most advanced chemical synthesis technology (Chen, 2018) . Alternatively, enzymes and microbes are natural catalysts for oligosaccharide synthesis and have become the most common biological method used for the production of trisaccharides (such as SL and fucosyllactose) or complex oligosaccharides (lacto-N-biose derivatives) (Han et al., 2012) . The 3′SL tested herein was enzymatically synthesized using a strain of beta-D-galactosidase deficient Escherichia coli (E. coli) BW25113 and a series of enzymes, including α2,3-sialyltransferase (Kim et al., 2018) . The objective of the study was to investigate the dose-dependent effects of this 3′SL sodium salt supplemented to a swine milk replacer on growth, hematological parameters and organ histology in the pre-clinical neonatal pig model. Of relevance, the doses chosen for the supplementation study closely reflect 3'SL concentrations found in human mature milk ten Bruggencate et al., 2014) and have been shown to exert biological effects in piglets (Mudd et al., 2017) . Neonatal piglets are considered a suitable model for the study of the impact of food ingredients to infant formula, because they share many characteristics with human infants in the perinatal development of the intestinal tract (Odle et al., 2014) . Furthermore, safety studies for the characterization of other HMO that are currently used in infant formula were conducted using the piglet model (Coulet et al., 2013 (Coulet et al., , 2014 Hanlon and Thorsrud, 2014) .
Materials and methods

Test ingredient
The test ingredient, 3′-SL sodium salt (> 98% purity), was produced by enzymatic synthesis and was provided in powdered form by GeneChem Inc. (Daejeon, South Korea). The characterization of the 3′SL sodium salt was previously described by Kim et al. (2018) and consist of a molecular weight of 655.54 g/mol (C 23 H 38 NO 19 Na) and its identity was confirmed by mass spectrometry and nuclear magnetic resonance spectroscopy. Quantitation was performed by high-performance anion exchange-chromatography. Impurities, which may potentially remain in the 3′-SL product, included lactose (0.25%), 3′-sialyl-galactose (0.46%) and sialic acid (0.49%).
Animal care and housing
Two-day-old piglets (n = 48; an equal proportion of males and females from 8 different litters; 3 to 12 piglets per litter) were obtained from the University of Illinois Swine Research Center and were transferred to the AAALAC-approved animal facilities in the Edward R. Madigan Laboratory on the University of Illinois campus where they were housed throughout the study. The animal study was conducted in 2 replicates, 2 weeks apart from each other. Per standard agricultural protocol, pigs were administered an intramuscular injection of iron hydrogenated dextran (1 mL, Butler Schein Animal Health, Dublin, OH, USA) and a prophylactic antibiotic (0.3 mL of ceftiofur crystalline free acid, Exceed, Zoetis, Parsippany, NJ, USA) within 24 h of birth. Additional antibiotic (0.15 mL) was given IM on days 7 and 14 of the study. Upon arrival to the animal facility, piglets were randomized to one of four dietary treatments described below, to balance initial BW and sex, and were housed individually in specialized neonatal piglet cages within environmentally controlled rooms (27°C) with a 12 h light/dark cycle. Additional heat was provided with heating pads and space heaters. All animal and experimental procedures were in accordance with the National Research Council Guide for the Care and Use of Laboratory Animals and approved by the University of Illinois at Urbana-Champaign Institutional Animal Care and Use Committee.
Dietary treatments
Piglets were fed one of four diets containing varying amounts of the 3′SL sodium salt. The control diet (formula alone, CON, N = 12) was a commercially-available non-medicated sow-milk replacer formula (Advance Liqui-Wean, Milk Specialties Co., Dundee, IL, USA), which was formulated to meet or exceed 2012 National Research Council requirements for 3-5 kg piglets. The remaining dietary treatments used the CON formula supplemented with 3′SL sodium salt at the following concentrations: 140 mg/L (LOW, N = 12), 200 mg/L (MOD, N = 12) or 500 mg/L (HIGH, N = 12). These concentrations corresponded to 135.3, 193.3 and 483 .2 mg/L of 3′SL, respectively. Piglets were weighed each morning prior to feeding to determine milk volume to be dispensed to individual animals. The formula was reconstituted fresh daily at the concentration of 183 g/L and piglets were provided 300 and 360 mL/kg BW on study days 1-5 and 6-21, respectively. Diets were delivered to the piglets 10-times over a period of 24 h via a peristaltic pump. After the 24 h period, any remaining milk was recorded to calculate accurately feed intake. Watery diarrhea over a period of 3 days was observed in 3 piglets in the LOW treatment group. These animals were removed from the study and the LOW group contained 9 animals, while all other groups contained 12 animals each.
Sample collection
On day 8 of the study (pig age = 10 days old), blood was collected via jugular vein in either plain or Sodium Citrate-laced vacutainers (BD Biosciences, Franklin Lakes, NJ, USA) to perform chemistry and coagulation time analyses, respectively. On day 22, animals were sedated with an intramuscular injection of Telazol ® (Tiletamine HCl and Zolazepam HCl, 3.5 mg/kg BW each, Pfizer Animal Health, Fort Dodge, IA) and blood was collected via cardiac puncture for chemistry, CBC and coagulation time analyses 3-6 h after the final feeding. Piglets were then euthanized by an intravenous injection of 86 mg/kg BW sodium pentobarbital (Euthasol, Virbac AH, Inc., Fort Worth, TX, USA). Urine samples were collected via cystocentesis at terminal necropsy for urinalysis. Spleen, stomach, kidneys, heart, lungs, and liver were immediately removed and weighed before a section was submerged in 10% buffered formalin for histopathological analysis. The small intestine was excised between the pyloric sphincter and ileocecal valve for measurement of total intestinal length. Then it was cut at 10% and 85% of the length from the proximal end to give 3 segments corresponding to the duodenum, jejunum and ileum, respectively. In addition, the large intestine was excised and length was taken from the cecum to the most distal part of the descending colon. At this time, cecal and colonic content were collected for pH measurement. Sections of the duodenum, jejunum, ileum, cecum, ascending and descending colon were fixed in formalin. Other tissue samples that were collected and fixed, but not weighed, included mesenteric lymph nodes, pancreas and gallbladder.
Microscopic histological analysis
Microscopic histological analyses were performed on tissue samples obtained from piglets fed the CON (0 mg/L) and HIGH (500 mg/L) diets by a board-certified pathologist at the University of Illinois College of Veterinary Medicine Diagnostic Lab. Parameters identified were: lymphoplasmacytic inflammation in the stomach, extramedullary hematopoiesis in cecum, spleen, liver and gallbladder, spleen congestion, glycogen depletion in the liver, kidney hemorrhage, and neutrophilic inflammation in the cecum, ascending and descending colon. Findings were reported as absent, minimal, mild, moderate or marked.
Hematological analyses and urinalysis
Serum chemistries and coagulation time (partial prothrombin time [PT] and activated partial thromboplastin time [aPTT]) were determined using an Olympus AU680 chemistry analyzer (Beckman Coulter, Brea, CA, USA) and a STA-Compact coagulation analyzer (Diagnostica STAGO, FRANCE), respectively. Serum was obtained after blood samples were centrifuged at 2,200×g for 20 min at 4°C in benchtop centrifuge (CS-6R Centrifuge, Beckman Coulter Life Sciences, Indianapolis, IN, USA). Serum chemistry analyses included concentrations of minerals (calcium, phosphorus, magnesium), electrolytes (sodium, potassium, chloride), protein (total protein, albumin and globulin), metabolites (glucose, total cholesterol, triglycerides, creatinine, urea, total bilirubin and bicarbonate), and the enzymes alkaline phosphatase (ALP), aspartate transaminase (AST), gamma-glutamyltransferase (GGT), creatine phosphokinase (CPK) and glutamate dehydrogenase (GLDH). In addition, complete cell blood count (CBC) was performed on CELL-DYN ® 3700 (Abbott, Abbott Park, IL, USA) while Diagnostic Lab trained technicians performed the differential analysis. The variables evaluated in our study were red blood cells count (RBC), hemoglobin concentration, hematocrit value, mean corpuscular volume (MCV), mean corpuscular hemoglobin (MCH), mean corpuscular hemoglobin concentration (MCHC), and corpuscular hemoglobin concentration mean. Total white blood cell (WBC) count and differential WBC analyses (neutrophils and lymphocytes) were also performed. Platelet indices were analyzed and included platelet count and mean platelet volume (MPV). Urinalysis was performed with the CLINITEK Advantus ® Urine Chemistry Analyzer (Siemens Healthcare, Germany), which provided the automated reading of pH, protein, glucose, ketones, bilirubin and blood. Specific gravity was measured on a refractometer and analysis of urine sediments and cells were done microscopically and classified as negative, rare, trace, few, moderate and many.
Statistical analysis
Analysis of variance (ANOVA) was conducted using the MIXED procedure of SAS 9.4 (SAS Inst. Inc., Cary, NC, USA) to differentiate dietary treatment effects on young pigs. Depending on the outcome, one of two statistical models were used: 1) any data collected at a single time-point (i.e., organ weights, urine analysis, intestinal content pH and CBC) were analyzed by a 1-way ANOVA, and 2) any data collected from the same animal on more than one occasion (i.e., daily BW, formula intake, chemistry and coagulation time) were analyzed by ANOVA with repeated-measures in which dietary treatment, time and treatment × time interaction were added to the statistical model. When dietary treatment or time was significant, with no interaction, data were pooled for statistical representation. When no effect of 3′-SL sodium salt treatment was observed, serum chemistry data were combined and analyzed for differences between day 8 and day 22. Normality was checked by the Shapiro-Wilk test and outliers were identified by a studentized residual procedure where values of > 3 or < -3 was considered as potential outliers. Categorical data (urinalysis and microscopic histological analysis were presented in frequency tables. and outcomes were analyzed with Fishers Exact Test to determine differences between the treatment groups. Data were expressed as mean ± standard deviation and statistical significance was defined at p < 0.05.
Results
Growth and body weight gain
Dietary supplementation of 3′-SL sodium salt at the concentrations of 140 (LOW), 200 (MOD), and 500 (HIGH) mg/L to a swine milk replacer formula was well tolerated by the neonatal piglets over the 21-day trial period. Three piglets in the LOW group were removed on study day 6-8 due to watery diarrhea. As there was no dose-response noted with higher SL amounts, we believe that this is incidental and not of toxicological concern. There were no differences in growth patterns (Supplemental Figure 1A ) or total BW gain over the study period did not significantly differ among the treatment groups (Supplemental Figure 1B) . No differences in growth between male and female piglets were observed (data not shown). Dietary 3′SL did not affect mean (mL) formula consumption (mL) or normalized by BW (Supplemental Figure 2) .
Organ weights and intestinal length, colonic contents pH
The neither normalized (Table 1 ) nor absolute intestinal length or organ weights (Supplemental Table 1 ), were affected by any dose of 3′SL. The colonic contents pH did not differ, however, the pH of the cecal contents of piglets fed the HIGH diet was significantly higher than the LOW and MOD groups, but did not differ from CON (Table 2) .
Organ microscopic histological analyses
Some minimal or mild microscopic findings were detected in a few tissues (Table 3 ). The most common observations were lymphoplasmacytic inflammation in the pyloric region of the stomach, splenic and hepatic extramedullary hematopoiesis. Congestion in the spleen, characterized by distension of sinuses within the splenic tissue caused by an accumulation of erythrocytes, was observed only in samples from two piglets fed the CON diet. Minimal lymphoplasmacytic and a Values are means ± SEM. 3′SL sodium salt supplementation had no effect on organ weights and intestinal length normalized by body weight.
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Regulatory Toxicology and Pharmacology 101 (2019) 57-64 neutrophilic inflammation were observed in the gallbladder and cecum and colon samples, but they were not diet-dependent. No histological differences were detected among piglets fed the four diets in the pancreas, mesenteric lymph nodes, lung, heart, duodenum, jejunum, ileum, ileal Peyer's patches or brain.
Hematological analyses and urinalysis
PT and aPPT were measured on study days 8 and 22 to characterize blood coagulation time (Table 4) . Feeding diets containing 3′SL sodium salt had no effect on PT and aPTT measures, but a time effect was observed as day 8 PT and aPTT values were significantly lower than day 22 (Fig. 1) . Blood chemistry values were all within reference ranges for both time points and 3′SL sodium salt supplementation had no effect on any parameter evaluated (Tables 5-6 and 7-8). Piglet age (e.g. day 8 vs day 22) significantly affected several serum chemistry measurements (Table 9 ). Serum calcium, magnesium, sodium, potassium, chloride, triglycerides, total protein, globulin, ASP, AST, GGT, total bilirubin and anion gap were all significant higher on day 8 than day 22, whereas the sodium:potassium ratio, glucose, albumin, albumin: globulin ratio, CKP, creatine, BUN and bicarbonate were lower on study day 8 than day 22.
CBC analysis with differential was performed on samples collected on day 22 (Supplemental Table 2 ). All samples were within expected ranges and there was no statistically significant effect on the parameters RBC, hemoglobin, hematocrit, MCV, MCH, MCHC, platelet, MPV, WBC, neutrophils and lymphocytes. Urine specific activity and pH did not differ among the treatment groups (data not shown). Most common findings in urine were white blood cells (83-91% of the samples) and epithelial cells (83-100% of the samples). The presence of crystals in urine were significantly higher in the HIGH compared to CON and MOD groups, (Supplemental Table 3 ). However, presence of crystals in 5 of the urine samples from the HIGH group were characterized as rare (n = 3) or few (n = 2).
Discussion
Feeding of formula supplemented with enzymatically synthesized 3′SL sodium salt at concentrations representative of those present in human milk to piglets over the first 3 weeks of life was well tolerated, supported growth performance comparable to those demonstrated previously in our lab (Berding et al., 2016) , and did not produce any adverse effects. The doses tested in this study (140, 200 and 500 mg/L) are within the range observed in human milk. A recent study that the 3′SL concentration in mature human milk ranged from 62 to 2992 mg/ mL, with an average concentration of 373 ± 229 mg/L (Azad et al., 2018) . Milk 3′SL content is influenced by the 2-α-L-fucosyltransferase 2 (FUT2) secretor status of the mother, but remains relatively stable throughout lactation (Azad et al., 2018; McGuire et al., 2017) . In pigs, the concentration of 3′SL decreased (P < 0.001) from days 0-7, then remained stable from days 7-18 of lactation. The concentration of 3′SL averaged 30 mg/L over the full course of lactation , The severity of findings was listed as absent (not listed), minimal, mild, moderate or marked.
No microscopic histological findings were observed in pancreas, mesenteric lymph nodes, lung, heart, duodenum, jejunum, ileum, ileal Peyer's patches and brain.
Table 4
Partial prothrombin time (PT) and activated partial thromboplastin time (aPTT) in serum of piglets fed formula containing various concentrations of 3′SL sodium salt on study days 8 and 22. 12.3-17.8 11.1 ± 0.5 10.7 ± 0.4 11.8 ± 0.6 11.7 ± 0.4 Day 22 PT (sec) 9.3-13.3 12.7 ± 0.2 12.8 ± 0.2 12.6 ± 0.3 12.7 ± 0.1 aPTT (sec) 12.3-17.8 13.6 ± 0.4 13.7 ± 0.4 13.5 ± 0.6 13.8 ± 0.5 a Values are means ± SEM. 3′SL sodium salt supplementation had no effect on PT or aPTT activity. b Range from 20-week-old Yucatan micropigs (Rispat et al., 1993) .
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Regulatory Toxicology and Pharmacology 101 (2019) [57] [58] [59] [60] [61] [62] [63] [64] which is ∼10-fold lower than human milk. Minor differences among the groups were observed for a few of the parameters tested, however, all values were within the expected ranges for 24-d-old piglets and there were no consistent dose-dependent effects, suggesting that the variation was most likely unrelated to the test ingredient. Our findings are in agreement with those of Jacobi et al. (2016) , who reported that piglets fed a diet supplemented with 3′SL demonstrated growth, feed intake and stool consistency similar to those observed in the control group. In addition, they detected an increase in ganglioside-bound SA in the corpus callosum and cerebellum of pigs fed 2 or 4 g 3′SL/day, respectively, 4-and 8-fold higher doses than the highest dose in our study. Orally administered 3′SL to human subjects with H. pylori infection at doses of 10 g or 20 g/d over a 21 day-period had high tolerability and a good safety profile (Parente et al., 2003) . Similarly, feed containing 5% 3′SL did not affect adult mice growth (Tarr et al., 2015) . In that same study, Tarr et al. observed the ability of 3'SL to alter the microbiota structure compared to mice fed a standard diet (Tarr et al., 2015) . Although microbiota analysis was not in the purview of our study, we detected an increase in pH of cecal contents in piglets receiving the highest dose (HIGH, 500 mg 3′SL/L). A study has shown that feeding a diet supplemented with prebiotics decreased the pH of cecal digesta (Alizadeh et al., 2016) , while Jacobi et al. (2016) did not observe any pH change in either the small or large intestine contents when piglets were fed diets supplemented with 3′SL, 6′SL or galactooligosaccharide. It is possible that changes in the microbiota occurred in HIGH leading to a change in cecal fermentation rate, thus affecting the pH. Future studies should test whether SL at the concentrations used herein modify the composition of the gut microbiota.
Organ microscopic evaluation was performed on samples collected from animals in the control diet or diet with the highest concentration of 3′SL sodium salt. The results indicated inflammatory processes in a few organs such as the pyloric region of the stomach, large intestine and Fig. 1 . Effect of postnatal age on partial prothrombin time (PT) and activated partial thromboplastin time (aPTT). Values are means ± SEM. N.S -not significant, p > 0.05. These data is also presented in Table 4 . Data were combined by time since treatment was not significant.
Table 5
Serum minerals, electrolytes, metabolites and proteins measured in the serum of piglets fed formula containing various concentrations of 3′SL sodium salt on study day 8. Minerals Calcium mg/dL 7.1-11.6 11.2 ± 0.2 11 ± 0.1 11.2 ± 0.1 11.2 ± 0.2 Phosphorous mg/dL 5.3-9.6 10.5 ± 0.2 9.9 ± 0.3 10.2 ± 0.2 10.1 ± 0.3 Magnesium mg/dL 2.7-3.7 3.1 ± 0.1 2.8 ± 0.1 2.9 ± 0.1 2.9 ± 0.1 Electrolytes Sodium mmol/L 135-150 142 ± 1.6 140 ± 1.0 140 ± 1.1 140 ± 1.4 Potassium mmol/L 4.4-6.7 7.2 ± 0.2 7.7 ± 0.2 7.4 ± 0.3 7.1 ± 0.4 Sodium:Potassium 20 ± 0.7 18 ± 0.5 19 ± 0.9 20 ± 0. 1.6 ± 0.1 1.6 ± 0.1 1.7 ± 0.1 1.8 ± 0.1 Globulin g/dL 1.9-3.9 2.4 ± 0.2 2.4 ± 0.1 2.6 ± 0.2 2.5 ± 0.2 Albumin:Globulin 0.8 ± 0.1 0.7 ± 0.04 0.7 ± 0.1 0.7 ± 0.05 a Values are means ± SEMs. b Ranges from 30-day-old pigs (Ventrella et al., 2017) .
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Regulatory Toxicology and Pharmacology 101 (2019) 57-64 gallbladder. Others have reported incidental microscopic findings that are independent of the test ingredients, but occasionally seen in the piglet of the age used in our study (Mahadevan et al., 2014; Hanlon and Thorsrud, 2014) . Our results indicated that the presence crystals in the urine of piglets fed the HIGH dose were more common than CON or MOD, however the number of crystals were characterized as rare or few. It is important to note that crystal formation in the urine can be a result of sampling and storage prior to analysis. Refrigeration of urine samples (1-5 h prior to analysis), is known to promote the formation of crystals (Pressler, 2010) .
Our pre-clinical safety assessment of 3′SL sodium salt as a food ingredient is supported by toxicological studies, in which the genotoxicity of 3′SL sodium salt was assessed in beagle dogs and rats (Kim et al., 2018) . The authors concluded that 3′SL sodium salt produced by enzymatic synthesis did not have any mutagenic and clastogenic potential and was safe for human consumption.
Human milk contains a wide variety of functional ingredients and is the optimum source of nutrition for the developing infant (WHO, 2009), however, breast-milk substitutes are needed in those situations where breastfeeding is not possible. The growing appreciation of the (Ventrella et al., 2017) . c Merck Veterinary Manual, Reference Guides (animal age unknown).
d Range from 6−week-old crossbred pigs (Cooper et al., 2014) . Protein Total Protein g/dL 3.7-4.8 3.7 ± 0.1 3.9 ± 0.1 3.8 ± 0.2 4.0 ± 0.1 Albumin g/dL 1.9-3.9 2.5 ± 0.1 2.6 ± 0.1 2.4 ± 0.1 2.7 ± 0.1 Globulin g/dL 1.9-3.9 1.3 ± 0.1 1.3 ± 0.1 1.3 ± 0.1 1.3 ± 0.1 Albumin:Globulin 2.0 ± 0.1 2.0 ± 0.2 1.9 ± 0.2 2.1 ± 0.1 a Values are means ± SEMs. b Ranges from 30-day-old pigs (Ventrella et al., 2017) .
Regulatory Toxicology and Pharmacology 101 (2019) 57-64 ability of HMO to modulate the immune system, gut bacterial colonization and brain development (Bode and Jantscher-Krenn, 2012; Donovan and Comstock, 2016; Mudd et al., 2017) , supports their addition to infant formulas (Chichlowski et al., 2011) . Currently, two neutral HMO, 2′fucosyllactose and lacto-N-neo-tetraose, have been tested in human clinical trials and are being added to commerciallyavailable infant formulas (Marriage et al., 2015; Puccio et al., 2017) . Although, studies of sialylated oligosaccharides conducted in humans (Smilowitz et al., 2017) and pre-clinical animal models (Cooper et al., 2017; Hester et al., 2013; Jacobi et al., 2016; Mudd et al., 2017; Tarr et al., 2015) have shown that SL is safe and supports positive clinical outcomes, SL has not yet been added to infant formulas. Until recently, the complexity of large-scale and cost-effective production of SL have been limiting factors to their addition to formulas. The production of 3′SL sodium salt by combining microbial and chemoenzymatic methods, such as the one used to produce the test ingredient used in the present study, represents a viable approach to overcome these barriers.
Conclusions
Our study provides evidence that supplementing 3′SL sodium salt to swine milk replacer at concentrations up to 500 mg/L is safe and supported similar growth and development of piglets fed the CON diet. Any clinical parameters affected by 3′SL were still within reference ranges and no dose-dependent effects were observed.
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